Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 OctoPlus Enters Formulation Pact | Contract Pharma

What are you searching for?

Sign in
Breaking News

OctoPlus Enters Formulation Pact

OctoPlus N.V. has signed a feasibility agreement with a top-10 biopharmaceutical company to develop a controlled release formulation for an undisclosed peptide compound.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

OctoPlus N.V. has signed a feasibility agreement with a top-10 biopharmaceutical company to develop a controlled release formulation for an undisclosed peptide compound. Pending a successful evaluation, the contract may result in a full process development, manufacturing and licensing agreement. Financial terms were not disclosed.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics